Search clinical trials for: multiple myeloma

Total 12888 results

IDEA AG

Completed

Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness

Muscle Soreness

Germany
DeveloGen Israel, Ltd.

Terminated

Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

Diabetes, Autoimmune

United States
Amgen

Completed

Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer

Anemia
National Center for Research Resources (NCRR)
University of Pennsylvania

Unknown

Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple Sclerosis

Multiple Sclerosis

United States
Save the Children
Harvard University; University of Westminster

Unknown

The Effectiveness of Micronutrient Supplements on Growth and Educational Achievement of Schoolchildren in Bangladesh

Micronutrient Deficiencies

Bangladesh
Cantonal Hospital of St. Gallen

Completed

Differential Immune Effects of Natalizumab

Multiple Sclerosis, Relapsing Remitting
Marilia Medicine School

Completed

Palliative Radiotherapy for Bone Metastases: Single Versus Multiple Fractions.

Pain | Bone Metastases

Brazil
Fortaleza University

Completed

Impairments of Oral Language in Mobius Syndrome (Mobius)

Möbius Sequence
Pfizer

Terminated

A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers

Healthy | Elderly

United States
Artielle ImmunoTherapeutics

Unknown

Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis

Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting

United States
Anza Therapeutics, Inc.

Terminated

Study of Safety and Tolerability of Multiple Intravenous Doses of ANZ-521 in Adults With Chronic Hepatitis C Virus

Chronic Hepatitis C

United States
Istanbul University

Completed

Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease

Autosomal Dominant Polycystic Kidney Disease

Turkey
Vertex Pharmaceuticals Incorporated

Completed

Single and Multiple Dose Escalation Study of VX-509 in Healthy Subjects

Healthy

United States
Teva GTC

Terminated

One Year Extension Study To Protocol C2/5/TZ:MS-05

Multiple Sclerosis | Spasticity

Israel
Radboud University Medical Center
Ipsen

Completed

Lanreotide as Treatment of Polycystic Livers (LOCKCYST)

Liver Diseases | Polycystic Kidney, Autosomal Dominant | Hepatomegaly | Polycystic Liver Disease

Netherlands, Belgium
University Hospital, Saarland
Pfizer

Unknown

Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe (AMORE-Eur)

Chronic Heart Failure | Cardiovascular High-Risk

Germany, Italy, Poland
University of Sao Paulo

Completed

Functional Communicative Profile of Children With Down Syndrome

Down Syndrome

Brazil
Nova Scotia Health Authority

Completed

Intensive Short-Term Dynamic Psychotherapy (ISTDP) in the Emergency Department (ISTDPED)

Somatic Complaints of Multiple Types

Canada
SCRI Development Innovations, LLC
Eli Lilly and Company; GlaxoSmithKline

Completed

Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies

Cervical Cancer | Ovarian Cancer | Lung Cancer | Endometrial Cancer

United States
National Center for Research Resources (NCRR)
Children's Hospital Medical Center, Cincinnati

Completed

Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease

Cholestasis | Biliary Atresia | Alagille Syndrome

United States
Teva GTC

Completed

Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity

Muscle Spasticity

Israel
US Department of Veterans Affairs

Completed

(PET) Imaging in the Management of Patients With Solitary Pulmonary Nodules

Benign and Malignant Solitary Pulmonary Nodules
University Of Perugia
University of Roma La Sapienza

Unknown

Botulinum A Toxin in Patients With Parkinson's Disease (Botox-PD)

Parkinson's Disease | Multiple System Atrophy | Detrusor Overactivity
Universidad Autónoma de Querétaro
Procter and Gamble

Completed

Evaluation of the Efficacy of Different Strategies to Treat Anemia in Mexican Children

Anemia
GAAD Medical Research Institute Inc.

Unknown

Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS)

Multiple Sclerosis

Canada
University of Vermont

Completed

Eszopiclone for Improving Sleep in Multiple Sclerosis (MS)

Fatigue | Sleep Initiation and Maintenance Disorders | Relapsing Remitting Multiple Sclerosis

United States
The Parkinson Study Group
United States Department of Defense

Unknown

Diagnostic and Prognostic Biomarkers in Parkinson Disease (PROBE)

Parkinson Disease | Multiple System Atrophy | Progressive Supranuclear Palsy

United States
Bayer

Completed

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients

Multiple Sclerosis, Relapsing-Remitting

Belgium, Israel, Sweden, United States, France, Switzerland, Ireland, Canada, Australia, Brazil, Austria, Poland, Germany, Hungary, Netherlands, Russian Federation, Spain, Argentina, Slovenia, Greece, Finland, Denmark, Ukraine, Italy, L... and more
Taichung Veterans General Hospital

Unknown

Exploring Stress and Coping Behaviors of the Major Carer Whose Children With Prader-Willi Syndrome

Prader-Willi Syndrome

Taiwan
AstraZeneca

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers

Healthy

Sweden
Neys-van Hoogstraten Foundation, The Netherlands

Completed

Efficacy of Multiple Micronutrient Fortified Biscuits and Deworming in Vietnamese School Children

Healthy

Thailand
Samsung Medical Center

Completed

Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome

Obesity | Prader-Willi Syndrome
Pfizer

Completed

A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers

Smoking Cessation

United States, United Kingdom
Pachyonychia Congenita Project

Completed

Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita

Pachyonychia Congenita

United States
Radboud University Medical Center
Ipsen

Unknown

Open-Label Extension of LOCKCYST Trial (LOCKCYST-ext)

Liver Diseases | Hepatomegaly | Polycystic Liver Disease | Polycystic Kidney | Autosomal Dominant

Netherlands, Belgium
AstraZeneca

Completed

Determine the Effect of Multiple Doses of AZD7325, CYP Study (CYP)

Healthy Volunteer
Avigen

Terminated

Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis

Muscle Spasticity

Czech Republic, Ukraine, Germany, Russian Federation, Serbia
Pontificia Universidade Catolica de Sao Paulo

Completed

Middle and Inner Ear Malformation in Children With Velocardiofacial Syndrome

Ear Malformations in the Velocardiofacial Syndrome
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects

Leukemia | Breast Cancer | Tumors

Netherlands
Catholic University of the Sacred Heart

Unknown

Anti-Inflammatory and Anti-Platelet Effect of Clopidogrel and Aspirin vs Aspirin Alone in Symptomatic Polyvascular Disease and in Patients With Multiple Recurrent Cardiovascular Events

Cardiovascular Disease | Polyvascular Disease

Italy
Logan College of Chiropractic

Completed

Whole Body Vibration Therapy in a Participant With Multiple Sclerosis Related Balance Deficits - A Case Study

Multiple Sclerosis

United States
Juvantia Pharma Ltd
Santhera Pharmaceuticals

Unknown

Fipamezole in Neurogenic Orthostatic Hypotension (Foehn)

Parkinson's Disease | Multiple System Atrophy | Symptomatic Neurogenic Orthostatic Hypotension (NOH)

France, Portugal
Pfizer

Terminated

An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend

Kidney Failure

United States
Icahn School of Medicine at Mount Sinai

Completed

Droxidopa in Treating Patients With Neurogenic Hypotension

Shy-Drager Syndrome | Orthostatic Hypotension

United States
Chi Mei Medical Hospital
GeneFerm Biotechnology Co., Ltd.

Completed

Efficacy and Safety of Geneferm Nattokinase

Hyperlipidemia

Taiwan
National Institute of Neurological Disorders and...
Mayo Clinic

Completed

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis

Multiple Sclerosis
Biogen

Terminated

How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose (TODAY)

Relapsing Remitting Multiple Sclerosis

Australia
Bristol-Myers Squibb

Completed

A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects

Parkinson's Disease

Canada
University of Aarhus
Sonderborg Hospital; The Danish Multiple Sclerosis Society

Completed

Multiple Sclerosis and Heavy Progressive Resistance Training

Multiple Sclerosis

Denmark
University Hospital, Strasbourg, France

Completed

Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults

Bardet-Biedl Syndrome | Orphan Diseases

France

Search clinical trials for: multiple myeloma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations